article thumbnail

Three Big Questions for Stage 3 & Patient Engagement

Chilmark Research

For many, the delay of Stage 3 of the Meaningful Use program evoked a collective sigh of relief, providing a much-needed extra year to focus on the challenging requirements for patient engagement and interoperability. Evidence for the positive impact of this data on quality, satisfaction, and in some cases cost is thin but growing.

article thumbnail

Healthcare 2020: Stop Treating Patients and Start Building Communities, Engaging Technology and Behavioural science

Lloyd Price

42 percent of all cancers are preventable, stemming from factors like an unhealthy diet, smoking, and a lack of exercise. Meaningfully use data to improve outcomes 5. Telling people to exercise, to go to the gym, doesn’t seem to work. That effectively means that 659,000 cancer cases never needed to happen,” Dhar said. “Is

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

FDA and Digital Health Regulation

Health Blawg

The agency has a history of articulating its position on where the line is to be drawn, on how it is to exercise its discretion in regulating devices. The agency has a history of articulating its position on where the line is to be drawn, on how it is to exercise its discretion in regulating devices.

article thumbnail

What the Marine Corps Taught Me about Working in the Healthcare Industry

care innovations

Everything I learned through boot camp, infantry training and all of my combat exercises shared one common fabric: Don’t always plan on an easy path to completing a mission. Quite a bit of this is inspired by ONC’s Meaningful Use, telehealth reimbursement models, and new CMS programs mandating effective change.

article thumbnail

FDA and Digital Health Regulation

Health Blawg

The agency has a history of articulating its position on where the line is to be drawn, on how it is to exercise its discretion in regulating devices. The agency has a history of articulating its position on where the line is to be drawn, on how it is to exercise its discretion in regulating devices.

article thumbnail

FDA and Digital Health Regulation

Health Blawg

The agency has a history of articulating its position on where the line is to be drawn, on how it is to exercise its discretion in regulating devices. The agency has a history of articulating its position on where the line is to be drawn, on how it is to exercise its discretion in regulating devices.

article thumbnail

FDA and Digital Health Regulation

Health Blawg

The agency has a history of articulating its position on where the line is to be drawn, on how it is to exercise its discretion in regulating devices. The agency has a history of articulating its position on where the line is to be drawn, on how it is to exercise its discretion in regulating devices.